Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Q2 2025 Earnings Call Transcript July 31, 2025 Aurinia Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.16 EPS, expectations were $0 ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

Amphastar is undervalued (~71% upside), but lacks an economic moat and faces modest growth, so I favor a cautious gradual ...

Ambiguity abounds around the terms for pharmaceutical goods under the U.S.-EU trade truce agreed Sunday. Pharma firms are urging clarity over whether their products will be subjec ...

Despite a new EU-US trade deal, tariffs on pharmaceuticals remain uncertain and unchanged for now, pending the outcome of a ...

India's Torrent Pharma reported a 20% jump in its first-quarter profit on Monday, driven by demand for drugs used to treat ...

ACADIA’s $1B+ 2025 revenue outlook is driven by NUPLAZID and DAYBUE, with ACP-101 offering optional upside despite risks.

Untangling the sprawling, global supply chain will be complicated and expensive, and could inadvertently compete with other ...

The pharmaceutical industry’s move toward increased U.S.-based manufacturing is changing the landscape of career ...

However, what does this all mean? Why does Bogavac's decision have meaning to UNC basketball and he has not even played a game yet? This is why.

Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.

Kennedy's criticism largely stems from his belief that modern medicine and mainstream science are part of a global conspiracy to generate pharmaceutical profits.